Get the Stockscreener App
63.00
0.93%
-0.75
Utah Medical Products Inc stock is traded at $63.00, with a volume of 3,265.
It is down -0.93% in the last 24 hours and down -0.89% over the past month.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
See More
Previous Close:
$63.75
Open:
$62.85
24h Volume:
3,265
Relative Volume:
0.21
Market Cap:
$200.83M
Revenue:
$44.08M
Net Income/Loss:
$15.26M
P/E Ratio:
14.75
EPS:
4.27
Net Cash Flow:
$16.91M
1W Performance:
-3.11%
1M Performance:
-0.89%
6M Performance:
+1.36%
1Y Performance:
+9.46%
1-Day Range:
$62.83
$63.15
1-Week Range:
$62.29
$65.33
52-Week Range:
$51.26
$68.71
Utah Medical Products Inc Stock (UTMD) Company Profile
Name
Utah Medical Products Inc
Sector
Industry
Phone
(801) 521-5301
Address
7043 S 300 WEST, MIDVALE, UT
Compare UTMD vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UTMD
Utah Medical Products Inc
|
63.03 | 203.12M | 44.08M | 15.26M | 16.91M | 4.27 |
|
ISRG
Intuitive Surgical Inc
|
475.19 | 175.03B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
158.97 | 46.42B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.73 | 39.37B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
233.18 | 34.98B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.34 | 34.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
Utah Medical Products Inc Stock (UTMD) Latest News
Mountain Lake Lodge Announces New Executive Leadership and Key Team Promotions - Weekly Voice
Global Minimally Invasive Surgical Devices Market to Witness Upsurge in Growth at a CAGR of ~7% by 2034 | DelveInsight - PR Newswire UK
(UTMD) Risk Channels and Responsive Allocation - Stock Traders Daily
Quarterly Earnings: Can Utah Medical Products Inc stock outperform in a bear marketSwing Trade & Daily Profit Maximizing Tips - baoquankhu1.vn
Can Utah Medical Products Inc sustain its profitabilityQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Biomedical Gas Analyzers Market Size to Reach 3,500 USD Million by 2035, Growing at 5.4% CAGR - industrytoday.co.uk
Aug Movers: Can Utah Medical Products Inc outperform under higher oil prices2025 Market Overview & Daily Volume Surge Signals - baoquankhu1.vn
Analysis Recap: Is Utah Medical Products Inc stock undervalued right now2025 Bull vs Bear & Weekly High Potential Alerts - baoquankhu1.vn
UTMD SEC FilingsUtah Med Prods 10-K, 10-Q, 8-K Forms - Stock Titan
Utah Medical Products (STU:UTM) 5-Year Dividend Growth Rate : 2.60% (As of Sep. 2025) - GuruFocus
Earnings Recap: Why is Utah Medical Products Inc stock going down2025 Momentum Check & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Utah Medical Products (STU:UTM) Altman Z-Score : 40.23 (As of Feb. 28, 2026) - GuruFocus
UTMD Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
(UTMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Electrosurgical Devices Market to Reach USD 10,220.04 Million by 2034, Growing at 6.34% CAGR | DelveInsight - openPR.com
Retail Trends: Is now the right time to enter RZLV2025 Fundamental Recap & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Utah Medical Products Inc (STU:UTM) Valuation: Modestly Overvalued - GuruFocus
Utah Medical Products (STU:UTM) Other Stockholders Equity : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Treasury Stock : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Retained Earnings : €109.02 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products Inc (STU:UTM) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Utah Medical Products (STU:UTM) Capital Expenditure : €-0.25 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Cash, Cash Equivalents, Mar - GuruFocus
Utah Medical Products (STU:UTM) Shareholder Yield % : 8.45% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Median PS Value - GuruFocus
Utah Medical Products (STU:UTM) FCF Yield % : 6.53 (As of Feb. 25, 2026) - GuruFocus
Utah Medical Products (STU:UTM) Debt-to-Equity : 0.00 (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Inventories, Other : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Long-Term Capital Lease Obl - GuruFocus
Utah Medical Products (STU:UTM) Minority Interest : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Operating Income : €10.00 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) 10-Year ROIIC % : 2.08% (As of Dec. 2024) - GuruFocus
Utah Medical Products (STU:UTM) YoY Rev. per Sh. Growth : 0.50% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Accounts Payable & Accrued Expense : €2.57 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Goodwill : €11.97 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Machinery, Furniture, Equipment : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) ROIC % : 23.16% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Short-Term Debt : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) 3-Year ROIIC % : 22.67% (As of Dec. 2024) - GuruFocus
Utah Medical Products (STU:UTM) Sale Of Property, Plant, Eq - GuruFocus
Utah Medical Products (STU:UTM) EPS (Basic) : €3.05 (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Interest Coverage : N/A (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) EV-to-OCF : 8.64 (As of Feb. 23, 2026) - GuruFocus
Utah Medical Products (STU:UTM) Common Stock : €0.03 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Net Income From Continuing Operations : €10.35 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products Inc (STU:UTM) Competitors 2026 - GuruFocus
Utah Medical Products (STU:UTM) EBIT : €10.00 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Payments to Suppliers for G - GuruFocus
Utah Medical Products (STU:UTM) Non Operating Income : €1.51 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Total Operating Expense : €9.25 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Other Current Assets : €0.36 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products Inc Stock (UTMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):